Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$305K Sell
2,688
-2,394
-47% -$323K ﹤0.01% 1840
2026
Q1
$724K Sell
5,082
-1
-0% -$158 0.01% 1247
2025
Q4
$886K Sell
5,083
-262
-5% -$48.7K 0.01% 1140
2025
Q3
$1.09M Sell
5,345
-269
-5% -$54.8K 0.01% 1011
2025
Q2
$967K Buy
5,614
+1,064
+23% +$171K 0.01% 1051
2025
Q1
$705K Buy
4,550
+1,836
+68% +$316K 0.01% 1171
2024
Q4
$499K Buy
2,714
+259
+11% +$49.1K 0.01% 1330
2024
Q3
$444K Buy
2,455
+620
+34% +$109K 0.01% 1394
2024
Q2
$333K Buy
+1,835
New +$328K ﹤0.01% 1528

Other funds holding PTC

Atria Investments's PTC Position: Q2 2026 in Review

Atria Investments reduced its PTC (PTC) stake by 47% in Q2 2026, selling an estimated $323K and leaving 2,688 shares worth $305K. The position accounts for ﹤0.01% of the portfolio, ranked #1840.

Atria Investments first reported a position in PTC in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.09M in Q3 2025. 685 funds tracked by Wall St. Rank hold PTC as of Q2 2026.

  • Atria Investments held 2,688 shares of PTC worth $305K as of Q2 2026.
  • Atria Investments sold 2,394 PTC shares in Q2 2026, an estimated $323K.
  • PTC made up ﹤0.01% of Atria Investments's portfolio in Q2 2026, its #1840 holding.
  • Atria Investments first reported a position in PTC in Q2 2024 and has held it in 9 quarters since.
  • Atria Investments's PTC position peaked at $1.09M in Q3 2025.
  • 685 funds tracked by Wall St. Rank held PTC as of Q2 2026.

Based on Atria Investments's 13F filing for Q2 2026, filed 28 Jul 2026.